Vimta Labs Ltd share price logo

Vimta Labs Share Price

NSE: VIMTALABS

BSE: 524394

Small Cap

Healthcare Sector

₹791.30

+14.35

(+1.85%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Vimta Labs Stock Performance

as on September 15, 2025 at 11:55 am IST

  • Day's Low

    Day's High

    ₹771.1
    ₹799.4
    downward going graph

    2.55%

    Downside

    1.02%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹251.53
    ₹902.65
    downward going graph

    68.21%

    Downside

    14.07%

    Upside

    downward going graph

Vimta Labs share price movements today

Previous Close
₹776.95
Open
₹791.55
Volume
7.07L
Upper Circuit
₹932.30
Lower Circuit
₹621.60
Day's Low - High
₹771.1 - ₹799.4
52 Week Low - High
₹251.53 - ₹902.65

Vimta Labs Historical Returns

1 Month Return
+ 16.98 %
3 Month Return
+ 59.96 %
1 Year Return
+ 142.08 %
3 Year Return
+ 333.61 %
5 Year Return
+ 1277.57 %

Vimta Labs Fundamentals

as on September 15, 2025 at 11:55 am IST

Market Cap

₹3,460.60 Cr

Return on Equity (ROE)

19.44

PE Ratio (TTM)

56.2

Return on capital employed (ROCE)

24.14

Industry PE ratio

52.59

Beta (LTM)

0.78

P/B Ratio

5.87

Dividend Yield

0

PEG Ratio

11.31

Quarterly Earnings Growth YOY

53.83

EPS (TTM)

9.25

Sector

Healthcare

Book Value

72.1

Technical Analysis

Bullish

View Technical Analysis

Vimta Labs Stock Valuation

as on September 15, 2025 at 11:55 am IST

Vimta Labs in the last 5 years

  • Overview

  • Trends

Lowest (13.76x)

March 20, 2023

Industry (52.59x)

September 12, 2025

Today (56.20x)

September 12, 2025

Highest (63.45x)

September 5, 2025

LowHigh

Today’s Price to Earnings Ratio: 56.20x

Vimta Labs Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Vimta Labs with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Vimta Labs Ltd image
Vimta Labs Ltd
NA3,460.60255.51%0.0041318
Kovai Medical Center & Hospital Ltd image
Kovai Medical Center & Hospital Ltd
NA6,912.7759.35%0.00NANA
Krsnaa Diagnostics Ltd image
Krsnaa Diagnostics Ltd
BUY2,681.38-3.25%0.6077723
Tarsons Products Ltd image
Tarsons Products Ltd
BUY1,665.09-12.35%0.6929392
Adeshwar Meditex Ltd image
Adeshwar Meditex Ltd
NA25.90-5.73%0.00283
See all

Vimta Labs Stock's Interest Amongst Investors

Investment in Vimta Labs Ltd Shares on INDmoney has dropped by -45.21% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-45.21% versus previous 30 day period

Search interest for Vimta Labs Ltd Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Vimta Labs Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Sales
79.85
77.38
81.82
83.49
65.54
74.58
79.69
74.88
84.74
89.92
Other Income
0.76
1.12
0.67
0.59
2.04
0.7
0.49
0.69
0.68
5.21
Total Income
80.62
78.51
82.49
84.07
67.58
75.28
80.18
75.57
85.43
95.13
Expenses
54.48
55.93
57.64
58.84
49.91
52.8
55.27
50.57
56.61
56.84
Operating Profit
25.37
21.45
24.18
24.65
15.63
21.78
24.42
24.31
28.13
33.08
Operating Profit Margin %
31.77%
27.72%
29.55%
29.52%
23.85%
29.2%
30.64%
32.47%
33.2%
36.79%
Profit Before Interest, Tax and Depreciation
26.14
22.58
24.84
25.24
17.67
22.48
24.91
25
28.82
38.29
Interest
0.8
0.65
0.25
0.44
0.61
0.53
0.53
0.47
0.41
0.58
Depreciation
7.58
7.85
8.04
8.5
8.65
8.43
8.09
7.98
8.29
9.81
Profit Before Tax
17.76
14.08
16.55
16.3
8.41
13.52
16.29
16.55
20.12
27.9
Tax Paid
4.55
3.84
3.87
4.1
2.08
3.39
3.93
4.26
4.88
6.4
Profit After Tax
13.21
10.24
12.68
12.2
6.33
10.13
12.35
12.28
15.25
21.5
Total Net profit including share of profit / Loss from associate company
13.21
10.24
12.68
12.2
6.33
10.13
12.35
12.28
15.25
21.5
EPS
5.97
4.62
5.73
5.51
2.86
3.61
5.58
5.54
6.88
9.65
Actual EPS
5.97
4.62
5.73
5.51
2.86
3.61
5.58
5.54
6.88
9.65
Adjusted EPS
2.99
2.31
2.87
2.76
1.43
1.81
2.79
2.77
3.44
4.83
Diluted EPS
5.85
4.51
5.64
5.4
2.83
3.56
5.51
5.47
6.75
9.56

Vimta Labs Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Sales
180.71
210.68
278.28
318.19
288.6
Other Income
3.02
0.83
1.45
3.44
3.71
Total Income
183.73
211.51
279.73
321.63
292.31
Expenses
150.76
157.72
199.22
223.28
202.36
Operating Profit
29.95
52.96
79.06
94.91
86.24
Operating Profit Margin %
16.57%
25.14%
28.41%
29.83%
29.88%
Profit Before Interest, Tax and Depreciation
32.97
53.79
80.51
98.36
89.95
Interest
3.77
2.17
1.5
2.65
2.1
Depreciation
20.93
23.08
23.33
30.71
33.14
Profit Before Tax
8.27
28.54
55.68
65
54.71
Tax Paid
1.42
7.14
14.36
16.83
13.69
Profit After Tax
6.85
21.41
41.33
48.17
41.01
Total Net profit including share of profit / Loss from associate company
6.85
21.41
41.33
48.17
41.01
EPS
3.1
9.68
18.7
21.77
18.52
Actual EPS
3.1
9.68
18.7
21.77
18.52
Adjusted EPS
1.55
4.84
9.35
10.89
9.26
Diluted EPS
3.1
9.68
18.32
21.35
18.25

Vimta Labs Ltd Cash Flow

Figures in Rupees Crores

Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Net Cash from Operating Activities
24.35
37.18
59.07
87.94
60.89
Cash Flow from Investing Activities
-20.84
-31.92
-37.85
-57.27
-76.05
Cash Flow from Financing Activities
-0.67
-4.58
-16.62
-10.99
-1.9
Net Cash Flow
2.84
0.69
4.61
19.7
-17.06

Vimta Labs Stock Shareholding Pattern

Numbers in percentages

Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
37.46%
37.25%
37.24%
37.23%
37.01%
36.98%
36.92%
36.89%
36.89%
36.76%
36.7%
36.67%
DII
1.48%
2.13%
2.14%
2.13%
1.5%
1.49%
1.5%
1.49%
0%
1.16%
1.43%
1.42%
FII
0%
0%
0%
0%
2.74%
0%
5.13%
5.16%
3.31%
3.81%
3.66%
3.49%
Public
60.02%
58.34%
58.38%
57.92%
58.75%
58.66%
56.45%
56.46%
59.8%
58.27%
58.2%
58.42%
Total Outstanding Shares
2,21,07,810
2,21,22,829
2,21,28,989
2,21,38,549
2,21,47,347
2,21,65,365
2,21,70,583
2,21,70,583
2,21,70,583
2,22,13,279
2,22,34,512
4,45,05,568
Total Shareholders
18,283
18,916
17,162
17,439
18,429
19,957
18,550
19,054
20,114
21,156
26,183
30,829

Mutual Funds that own Vimta Labs Stock

Check out the Mutual Funds with significant holdings in Vimta Labs.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.07%
204

Vimta Labs Earnings and Dividends

View detailed summary of the earnings and dividend history of Vimta Labs.

  • Vimta Labs Ltd Earnings Results

    Vimta Labs Ltd’s net profit jumped 53.83% since last year same period to ₹18.89Cr in the Q1 2025-2026. On a quarterly growth basis, Vimta Labs Ltd has generated 3.11% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Vimta Labs Ltd Dividends April,2025

    In the quarter ending March 2025, Vimta Labs Ltd has declared dividend of ₹2.00 per share on 28 Apr 2025 - translating a dividend yield of 0.51%.

    Read More about Dividends

Indices Featuring Vimta Labs Stock

Check stock indices that include Vimta Labs.

BSE Healthcare

₹44,741.20

-0.4 (▲-181.37%)

BSE Small-Cap

₹53,875.53

0.61 (▲327.04%)

Insights on Vimta Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 58.20% to 58.42% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 12.28 Cr → 21.5 Cr (in ₹), with an average increase of 24.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 5 quarters, 75.57 Cr → 99.31 Cr (in ₹), with an average increase of 6.5% per quarter

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 36.70% to 36.67% in Jun 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, VIMTALABS stock has moved down by -6.8%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 3.66% to 3.49% in Jun 2025 quarter

About Vimta Labs Ltd

Vimta Labs Ltd., founded in 1984, is India's premier contract research and testing organization. They provide a wide range of services to several different industries such as pharmaceutical, biopharmaceutical, food, consumer goods, electronic-electrical, agrochemical, healthcare, medical devices and many others. These services range from drug discovery development, preclinical research, GLP and nonGLP clinical research, cGMP and non-GMP analytical services, preclinical research and testing for medical device companies, contract research and testing for agroscience companies, food testing and analytical development services, clinical diagnostics services, environmental regulatory services and more. Vimta was awarded ISO 9002 certification in 1994 and entered a joint venture in 1997 with ROSTEST Moscow, making an investment of 24 of the total Paidup Capital. In 2002, the Company began offering clinical diagnostics services. In 2020, Vimta acquired 100 Equity Shares of Emtac Laboratories Private Limited, making Emtac a wholly owned subsidiary of the Company. With a goal of expanding operations, they are in the process of constructing a five-times-larger facility in S.P.Biotech Park Genome Valley Hyderabad. By providing comprehensive services, certification and joint ventures, Vimta Labs Ltd. has become India's leading contract research and testing organization.

Revenue: ₹97.56Cr as on June 2025 (Q1 FY26)
Net Profit: ₹18.89Cr as on June 2025 (Q1 FY26)
Listing date: 15 Dec, 2005
Chairperson Name: S P Vasireddi
OrganisationVimta Labs Ltd
IndustryHealthcare
CEOS P Vasireddi
E-voting on sharesClick here to vote

FAQs

What is Vimta Labs share price today?

Vimta Labs share price today stands at ₹791.3 as on . Vimta Labs share today touched a day high of ₹799.4 and a low of ₹771.1.

What is the 52 week high and 52 week low range for Vimta Labs share?

Vimta Labs touched a 52 week high of ₹902.65 and a 52 week low of ₹251.53. Vimta Labs share price today i.e. is trending at ₹791.3, which is -12.34% down from its 52 week high and 214.59% up from its 52 week low.

What is Vimta Labs's market capitalisation today?

Vimta Labs market capitalisation is ₹3,460.60 Cr as on .

How to buy Vimta Labs shares?

To buy Vimta Labs shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for VIMTALABS or Vimta Labs Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Vimta Labs shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Vimta Labs trading volume today?

Vimta Labs trading volume is 7.07L as on . This means that 7.07L shares of Vimta Labs were bought and sold on the stock market during today's trading session.